BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 33200334)

  • 1. Experimental autoimmune prostatitis: different antigens induction and antigen-specific therapy.
    Liu Y; Wazir J; Tang M; Ullah R; Chen Y; Chen T; Zhou X
    Int Urol Nephrol; 2021 Apr; 53(4):607-618. PubMed ID: 33200334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of alcohol on chronic pelvic pain and prostatic inflammation in a mouse model of experimental autoimmune prostatitis.
    Zhang LG; Chen J; Meng JL; Zhang Y; Liu Y; Zhan CS; Chen XG; Zhang L; Liang CZ
    Prostate; 2019 Sep; 79(12):1439-1449. PubMed ID: 31233226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel murine model of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) induced by immunization with a spermine binding protein (p25) peptide.
    Altuntas CZ; Daneshgari F; Veizi E; Izgi K; Bicer F; Ozer A; Grimberg KO; Bakhautdin B; Sakalar C; Tasdemir C; Tuohy VK
    Am J Physiol Regul Integr Comp Physiol; 2013 Mar; 304(6):R415-22. PubMed ID: 23344231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of GM-CSF in a mouse model of experimental autoimmune prostatitis.
    Liu Y; Li Y; Liu Q; Wu Z; Cui J; Zhu K; Zhao H; Zhou C; Shi B
    Am J Physiol Renal Physiol; 2019 Jul; 317(7):F23-F29. PubMed ID: 30943070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T2 Peptide Represents a Major Autoantigen Epitope in Experimental Autoimmune Prostatitis.
    Liu Y; Tang M; Zhang Q; Li C; Lv R; Min H; Zhou X
    Inflammation; 2021 Feb; 44(1):243-248. PubMed ID: 32827084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Li-ESWT treatment reduces inflammation, oxidative stress, and pain via the PI3K/AKT/FOXO1 pathway in autoimmune prostatitis rat models.
    Feng B; Dong Z; Wang Y; Yan G; Yang E; Cheng H; Liang C; Hao Z; Zhang X; Song Z; Jiang Z; Chen M; Yue Z; Wang Z
    Andrology; 2021 Sep; 9(5):1593-1602. PubMed ID: 33960707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL17 Mediates Pelvic Pain in Experimental Autoimmune Prostatitis (EAP).
    Murphy SF; Schaeffer AJ; Done J; Wong L; Bell-Cohn A; Roman K; Cashy J; Ohlhausen M; Thumbikat P
    PLoS One; 2015; 10(5):e0125623. PubMed ID: 25933188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRPV1 in experimental autoimmune prostatitis.
    Roman K; Hall C; Schaeffer AJ; Thumbikat P
    Prostate; 2020 Jan; 80(1):28-37. PubMed ID: 31573117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Eriocalyxin B on prostatic inflammation and pelvic pain in a mouse model of experimental autoimmune prostatitis.
    Zhang LG; Yu ZQ; Yang C; Chen J; Zhan CS; Chen XG; Zhang L; Hao ZY; Liang CZ
    Prostate; 2020 Dec; 80(16):1394-1404. PubMed ID: 32965686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated autophagy restored the impaired frequency and function of regulatory T cells in chronic prostatitis.
    Liu Y; Zhang Y; Zhang M; Meng J; Ma Q; Hao Z; Zheng M; Zhang L; Chen X; Liang C
    Prostate; 2021 Jan; 81(1):29-40. PubMed ID: 33085775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of a rat model of chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) induced by immunization with a novel peptide T2.
    Ihsan AU; Khan FU; Nawaz W; Khan MZ; Yang M; Zhou X
    Biomed Pharmacother; 2017 Jul; 91():687-692. PubMed ID: 28499240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nanoparticle-coupled T2 peptide induces immune tolerance and ameliorates chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) in mice model.
    Cao Y; Cheng Y; Ihsan AU; Khan FU; Xie D; Cui X; Wang W; Zhou X
    Fundam Clin Pharmacol; 2019 Jun; 33(3):267-276. PubMed ID: 30471234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphological reseach on expression of inflammatory mediators in murine models of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) induced by T2 antigen.
    Wang W; Naveed M; Majeed F; Cui X; Ihsan AU; Liu Z; Zubair HM; Tang M; Sohail M; Xiaohui Z
    Andrologia; 2019 Dec; 51(11):e13435. PubMed ID: 31613015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune prostatitis: state of the art.
    Motrich RD; Maccioni M; Riera CM; Rivero VE
    Scand J Immunol; 2007; 66(2-3):217-27. PubMed ID: 17635799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with chronic prostatitis/chronic pelvic pain syndrome show T helper type 1 (Th1) and Th17 self-reactive immune responses specific to prostate and seminal antigens and diminished semen quality.
    Motrich RD; Breser ML; Molina RI; Tissera A; Olmedo JJ; Rivero VE
    BJU Int; 2020 Sep; 126(3):379-387. PubMed ID: 32437049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological alterations in patients with chronic prostatitis/chronic pelvic pain syndrome and experimental autoimmune prostatitis model: A systematic review and meta-analysis.
    Chen L; Bian Z; Chen J; Meng J; Zhang M; Liang C
    Cytokine; 2021 May; 141():155440. PubMed ID: 33550164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astaxanthin alleviates chronic prostatitis/chronic pelvic pain syndrome by increasing colonization of Akkermansia muciniphila in the intestine.
    Liu YF; Xie WJ; Xi P; Zhang ZC; Chen R; Fu SQ; Lei KY; Liu J; Cheng XF; Nie YC; Yang XR; Ma M; Sun T; Gong BB
    Phytomedicine; 2024 Jan; 123():155249. PubMed ID: 38056144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tryptase-PAR2 axis in experimental autoimmune prostatitis, a model for chronic pelvic pain syndrome.
    Roman K; Done JD; Schaeffer AJ; Murphy SF; Thumbikat P
    Pain; 2014 Jul; 155(7):1328-1338. PubMed ID: 24726923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic Pelvic Pain Development and Prostate Inflammation in Strains of Mice With Different Susceptibility to Experimental Autoimmune Prostatitis.
    Breser ML; Motrich RD; Sanchez LR; Rivero VE
    Prostate; 2017 Jan; 77(1):94-104. PubMed ID: 27699823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenic Roles of CXCL10 in Experimental Autoimmune Prostatitis by Modulating Macrophage Chemotaxis and Cytokine Secretion.
    Hua X; Ge S; Zhang M; Mo F; Zhang L; Zhang J; Yang C; Tai S; Chen X; Zhang L; Liang C
    Front Immunol; 2021; 12():706027. PubMed ID: 34659199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.